Astellas Pharma Inc: all 983 studies

Page 7 of 10. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.

• A Study to Assess the Safety and Pharmacokinetics of Isavuconazole in Healthy Chinese VolunteersCompletedNCT01555918Phase 1
• Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole.CompletedNCT01555866Phase 1
• A Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to MethotrexateCompletedNCT01554696Phase 2
• An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional UrodynamicsTerminatedNCT01540786Phase 1
• Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive BladderCompletedNCT01539707Phase 1
• Drug Interaction Study of Isavuconazole and TacrolimusCompletedNCT01535547Phase 1
• To Determine the Feasibility of a Fidaxomicin Study in Neonates and to Assess C. Difficile (Clostridium Difficile) Involvement in the PathogenesisTerminatedNCT01533844
• A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the BodyCompletedNCT01529684Phase 1
• A Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes MellitusTerminatedNCT01514838Phase 3
• A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly SubjectsCompletedNCT01514825Phase 1
• A Study to Investigate the Effect of YM150 on the Plasma Concentration of Digoxin in Healthy SubjectsCompletedNCT01514812Phase 1
• A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)CompletedNCT01511003Phase 4
• A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes PatientsCompletedNCT01505426Phase 3
• Drug Interaction Study of Isavuconazole and CyclosporineCompletedNCT01494597Phase 1
• Post Marketing Survey of Vesicare in JapanCompletedNCT01489709
• A Study to Evaluate Cardiovascular Interactions Between Mirabegron and TamsulosinCompletedNCT01489696Phase 1
• A Single Oral Dose Study of ASP015K in Healthy Volunteers Assessing the Relative Bioavailability Across Three Tablet Strengths From a New Formulation of ASP015KCompletedNCT01486017Phase 1
• A Single Oral Dose Study to Compare the Bioavailability Between Two Different Tablet Formulations and Assess if There is a Food Effect With the New FormulationCompletedNCT01484964Phase 1
• A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic PatientsCompletedNCT01478607Phase 3
• To Evaluate the Effect of Mirabegron (YM178) on Blood Levels of Desipramine When They Are Taken TogetherCompletedNCT01478568Phase 1
• A Study to Find Out How Much Mirabegron Gets Into the Body After Dosing With a Tablet FormulationCompletedNCT01478529Phase 1
• To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly FemalesCompletedNCT01478503Phase 1
• To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of MetoprololCompletedNCT01478490Phase 1
• A Study to Assess Pharmacokinetic Interaction of Multiple Dose Ketoconazole on Single Dose YM178 Oral Controlled Absorption System (OCAS) in Healthy Adult VolunteersCompletedNCT01476800Phase 1
• Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)CompletedNCT01469832Phase 1/2
• Special Drug Use-Results Survey of Lipitor TabletsCompletedNCT01446679
• A Study to Evaluate the Effect of ASP8597 in Adult Kidney Transplant PatientsTerminatedNCT01442337Phase 2/3
• A Study to Assess the Bioavailability of ASP015KCompletedNCT01430078Phase 1
• Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Tacrolimus in Healthy VolunteersCompletedNCT01430065Phase 1
• A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy SubjectsCompletedNCT01427387Phase 1
• To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their EffectsCompletedNCT01424332Phase 1
• Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult MalesCompletedNCT01423435Phase 1
• Method of Pre-treatment for Application of QUTENZA Capsaicin 8% PatchCompletedNCT01416116Phase 4
• A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use SituationsCompletedNCT01410747
• To Evaluate Whether Acetyl Salicylic Acid (Aspirin), the Combination of Aspirin and Clopidogrel and Darexaban (YM150) Interact in Their EffectsCompletedNCT01409616Phase 1
• To Evaluate Whether Naproxen and Darexaban (YM150) Interact in Their EffectsCompletedNCT01409603Phase 1
• A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4CompletedNCT01409135Phase 1
• Drug Interaction Study of Isavuconazole and MidazolamCompletedNCT01406171Phase 1
• A Study in Healthy Volunteers Comparing Two Different Liquid Formulations of Solifenacin With Each Other and With the Tablet FormulationCompletedNCT01406158Phase 1
• A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of DonepezilCompletedNCT01406145Phase 1
• A Study to Assess the Pharmacokinetics of ASP015K in Healthy Male SubjectsCompletedNCT01406132Phase 1
• To Evaluate if Multiple Doses of Rifampicin Change the Blood Concentration of YM150 (Darexaban)CompletedNCT01406002Phase 1
• To Evaluate if Multiple Doses of Ketoconazole Change the Blood Concentration of YM150 (Darexaban)CompletedNCT01405989Phase 1
• A Study to Assess the Effect of ASP1941 and Mitiglinide on Their Plasma ConcentrationCompletedNCT01403818Phase 1
• Study of an Investigational Drug, ASP3026, in Patients With Solid TumorsCompletedNCT01401504Phase 1
• A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet and Conventional Tablet Under With Water IntakeCompletedNCT01394653Phase 1
• A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet (Without Water) and Conventional TabletCompletedNCT01392794Phase 1
• A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)CompletedNCT01391338Phase 2
• A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015KCompletedNCT01387087Phase 1
• A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ASP1941 in Healthy Male Taiwanese SubjectsCompletedNCT01373060Phase 1
• A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft RecipientsTerminatedNCT01371344Phase 4
• A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ TransplantationCompletedNCT01371331Phase 4
• Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Mycophenolate Mofetil in Healthy VolunteersCompletedNCT01364987Phase 1
• A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015KCompletedNCT01364974Phase 1
• A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.CompletedNCT01363752Phase 4
• Phase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) PatientsTerminatedNCT01352208Phase 1/2
• Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular DystrophyCompletedNCT01345006Phase 1/2
• Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular DegenerationCompletedNCT01344993Phase 1/2
• A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis PatientsTerminatedNCT01342016Phase 3
• A Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating AbataceptCompletedNCT01339481
• A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver TransplantationCompletedNCT01339468Phase 4
• A Study to Investigate the Safety and Effect of Food on the Pharmacokinetics of YM178 in Healthy VolunteersCompletedNCT01334905Phase 1
• Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®CompletedNCT01332201Phase 2
• A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia GravisCompletedNCT01325571Phase 3
• A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin TreatmentCompletedNCT01318837Phase 4
• A Study Measuring and Tracking Changes in Overactive Bladder (OAB) MedicationWithdrawnNCT01317810
• A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis PatientsTerminatedNCT01316133Phase 4
• A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic PatientsCompletedNCT01316107Phase 3
• A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal ImpairmentCompletedNCT01316094Phase 3
• A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without SteroidsCompletedNCT01304836Phase 4
• Drug-drug Interaction Study With ASP1941 and GlimepirideCompletedNCT01302158Phase 1
• Drug to Drug Interaction Study With ASP1941 and MetforminCompletedNCT01302145Phase 1
• Mass Balance Study of ASP1941CompletedNCT01302132Phase 1
• Renal Impairment Study With ASP1941CompletedNCT01302028Phase 1
• A Clinical Study to Assess the Effect on Pharmacokinetics of Dosing Mirabegron (YM178) and Solifenacin SimultaneouslyCompletedNCT01297192Phase 1
• A Study to Evaluate the Possible Effects of Taking Mirabegron While Taking a Contraceptive PillCompletedNCT01297179Phase 1
• Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®CompletedNCT01294020Phase 2
• Multiple Dose Escalating Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1941CompletedNCT01288898Phase 1
• First in Men Study of Single Oral Doses of ASP1941 in Healthy SubjectsCompletedNCT01288885Phase 1
• A Study to Evaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and SexCompletedNCT01285596Phase 1
• A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer PatientsCompletedNCT01284920Phase 1/2
• A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.CompletedNCT01284868Phase 1
• A Study to Assess Intraocular Pressure and Ocular Safety of the Beta-3 Agonist Mirabegron in Research SubjectsCompletedNCT01284309Phase 1
• Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)CompletedNCT01284192Phase 1
• A Safety and Pharmacokinetics Study of ASP0456 in Healthy SubjectsCompletedNCT01279915Phase 1
• A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de Novo Kidney TransplantationCompletedNCT01279538Phase 1
• A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female PatientsCompletedNCT01274000Phase 2
• Single-dose Study to Assess Pharmacokinetics of Solifenacin Succinate Suspension in Children and AdolescentsCompletedNCT01262391Phase 1
• Study to Find Maintenance Dose for Periodic Administration of ASP3550CompletedNCT01261572Phase 2
• Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve DamageCompletedNCT01252160Phase 4
• A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic PatientsCompletedNCT01242228Phase 3
• A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic PatientsCompletedNCT01242215Phase 3
• A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic PatientsCompletedNCT01242202Phase 3
• A Study of the Effect of ASP1941 on Cardiac Repolarization in Healthy SubjectsCompletedNCT01232413Phase 1
• A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate CancerCompletedNCT01228760Phase 1
• A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male PatientsCompletedNCT01225237Phase 4
• Single and Multiple Oral Administration Study of ASP015K in Healthy Nonelderly VolunteersCompletedNCT01225224Phase 1
• A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic PatientsCompletedNCT01225081Phase 3
• A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to MethotrexateCompletedNCT01224418Phase 4
• Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to MethotrexateCompletedNCT01224041Phase 4

← Astellas Pharma Inc overview and focus areas